Breaking News Instant updates and real-time market news.

SYK

Stryker

$218.72

0.965 (0.44%)

08:26
08/12/19
08/12
08:26
08/12/19
08:26

TSO3 to be acquired by Stryker for C$0.43 in cash per share

  • 09

    Sep

SYK Stryker
$218.72

0.965 (0.44%)

07/15/19
BTIG
07/15/19
NO CHANGE
Target $219
BTIG
Buy
Stryker price target raised to $219 from $205 at BTIG
BTIG analyst Ryan Zimmerman raised his price target on Stryker to $219 and kept his Buy rating as part of his Q2 MedTech earnings preview research note, saying the quarter should prove to be "more defensive than opportunistic" and that investors should consider long-short sector strategies over momentum-driven trades. The analyst is positive on Stryker's capital order book and believes that it has a clear line of sight on growth through FY19, adding that the company is also growing the staff count as intended.
07/26/19
PIPR
07/26/19
NO CHANGE
Target $240
PIPR
Overweight
Stryker price target raised to $240 from $205 at Piper Jaffray
Piper Jaffray analyst Matt O'Brien raised his price target for Stryker to $240 from $205 after the company reported fiscal Q2 results that beat top and bottom line expectations, and raised its full-year growth and earnings outlook. Domestic Mako placements, up 30% year-over-year came in ahead of expectations, and momentum across the entire MedSurg business carried the majority of the beat, O'Brien tells investors in a research note. In addition, a number of new products are coming in the second half of the year, as well as "meaningful" operating leverage from efficiency initiatives, says the analyst. He maintains an Overweight rating on Stryker.
07/26/19
CANT
07/26/19
NO CHANGE
Target $230
CANT
Overweight
Stryker price target raised to $230 from $190 at Cantor Fitzgerald
Cantor Fitzgerald analyst Craig Bijou raised his price target for Stryker to $230 from $190 citing the company's "impressive" Q2 results. The analyst, however, thinks investor expectations for the stock "remain lofty." He keeps a Neutral rating on the shares.
07/26/19
ADAM
07/26/19
NO CHANGE
Target $233
ADAM
Buy
Stryker price target raised to $233 from $195 at Canaccord
Canaccord analyst Kyle Rose raised his price target on Stryker to $233 from $195 following strong Q2 results. The analyst said there was momentum across the entire portfolio and operationally, its earnings reflected strong sales growth and operating expense improvements. Rose reiterated his Buy rating on Stryker shares.

TODAY'S FREE FLY STORIES

WW

WW

$28.25

0.01 (0.04%)

10:25
08/21/19
08/21
10:25
08/21/19
10:25
Options
Weight Watchers call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
08/21/19
08/21
10:25
08/21/19
10:25
General news
Treasury Action: the slight beat in existing home sales didn't really impact »

Treasury Action: the…

10:20
08/21/19
08/21
10:20
08/21/19
10:20
General news
The U.S. July existing home sales report beat estimates »

The U.S. July existing…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
08/21/19
08/21
10:17
08/21/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOOM

DMC Global

$42.78

1.375 (3.32%)

10:17
08/21/19
08/21
10:17
08/21/19
10:17
Conference/Events
DMC Global management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 13

    Nov

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
08/21/19
08/21
10:16
08/21/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFL

Aflac

$49.57

-2.29 (-4.42%)

10:15
08/21/19
08/21
10:15
08/21/19
10:15
Options
AFLAC put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
08/21/19
08/21
10:15
08/21/19
10:15
General news
Breaking General news story  »

Week of 8/16 EIA…

HSGX

Histogenics

$0.22

0.0005 (0.23%)

10:14
08/21/19
08/21
10:14
08/21/19
10:14
Hot Stocks
Histogenics merger partner Ocugen granted FDA orphan designation »

Ocugen's treatment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYCN

Cyclerion Therapeutics

$9.59

0.8 (9.10%)

10:12
08/21/19
08/21
10:12
08/21/19
10:12
Upgrade
Cyclerion Therapeutics rating change  »

Cyclerion Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFL

Aflac

$49.65

-2.21 (-4.26%)

10:11
08/21/19
08/21
10:11
08/21/19
10:11
Recommendations
Aflac analyst commentary  »

Aflac third sector sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLFD

Clearfield

$10.98

(0.00%)

, WSG

Wanda Sports

$4.12

0.22 (5.64%)

10:10
08/21/19
08/21
10:10
08/21/19
10:10
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

CLFD

Clearfield

$10.98

(0.00%)

WSG

Wanda Sports

$4.12

0.22 (5.64%)

INMB

INmune Bio

$6.30

0.46 (7.88%)

CLGX

CoreLogic

$47.28

0.49 (1.05%)

HUBB

Hubbell

$127.70

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 05

    Sep

  • 12

    Sep

  • 13

    Nov

CREE

Cree

$52.88

-5.31 (-9.13%)

, HA

Hawaiian Holdings

$23.94

-1.5 (-5.90%)

10:10
08/21/19
08/21
10:10
08/21/19
10:10
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

CREE

Cree

$52.88

-5.31 (-9.13%)

HA

Hawaiian Holdings

$23.94

-1.5 (-5.90%)

CIM

Chimera

$19.52

-0.17 (-0.86%)

SYBX

Synlogic

$3.25

-0.22 (-6.34%)

JAZZ

Jazz Pharmaceuticals

$134.12

-2.42 (-1.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 04

    Sep

  • 05

    Sep

  • 09

    Sep

  • 30

    Oct

NOW

ServiceNow

$263.94

8.44 (3.30%)

, EEX

Emerald Expositions Events

$9.73

0.24 (2.53%)

10:10
08/21/19
08/21
10:10
08/21/19
10:10
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

NOW

ServiceNow

$263.94

8.44 (3.30%)

EEX

Emerald Expositions Events

$9.73

0.24 (2.53%)

PSA

Public Storage

$261.11

0.66 (0.25%)

LSI

Life Storage

$104.00

0.68 (0.66%)

ONDK

On Deck Capital

$3.26

0.025 (0.77%)

RDFN

Redfin

$18.28

0.83 (4.76%)

RMAX

RE/MAX Holdings

$27.38

0.71 (2.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 28

    Aug

  • 18

    Sep

  • 27

    Oct

  • 13

    Nov

  • 12

    Dec

  • 16

    Dec

10:10
08/21/19
08/21
10:10
08/21/19
10:10
General news
FX Action: The dollar »

FX Action: The dollar…

10:10
08/21/19
08/21
10:10
08/21/19
10:10
General news
U.S. July existing home sales rebounded 2.5% to 5.420 M »

U.S. July existing home…

PFE

Pfizer

$34.96

0.34 (0.98%)

10:03
08/21/19
08/21
10:03
08/21/19
10:03
Hot Stocks
Pfizer announces additional half billion dollar investment for Sanford facility »

Pfizer announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 16

    Sep

LKSD

LSC Communications

$1.34

0.01 (0.75%)

10:03
08/21/19
08/21
10:03
08/21/19
10:03
Hot Stocks
UBM acquires commingle operations from LSC Communications for $11.25M in cash »

LSC Communications and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:02
08/21/19
08/21
10:02
08/21/19
10:02
General news
Existing Home Sales data reported »

July Existing Home Sales…

HURN

Huron

$60.80

(0.00%)

10:02
08/21/19
08/21
10:02
08/21/19
10:02
Conference/Events
Huron management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 29

    Aug

  • 10

    Sep

  • 11

    Sep

  • 17

    Sep

  • 18

    Sep

HURN

Huron

$60.80

(0.00%)

10:01
08/21/19
08/21
10:01
08/21/19
10:01
Conference/Events
Huron management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 29

    Aug

  • 10

    Sep

  • 11

    Sep

  • 17

    Sep

  • 18

    Sep

SPY

SPDR S&P 500 ETF Trust

$292.80

2.77 (0.96%)

, SPX

S&P 500

$0.00

(0.00%)

10:01
08/21/19
08/21
10:01
08/21/19
10:01
General news
Trump tweets about German bonds, asks 'Where is the Federal Reserve?' »

President Donald Trump…

SPY

SPDR S&P 500 ETF Trust

$292.80

2.77 (0.96%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$107.98

9.94 (10.14%)

10:00
08/21/19
08/21
10:00
08/21/19
10:00
Hot Stocks
Lowe's says seeing increased Pro customer service scores »

Says: Has laundry list of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 25

    Sep

TSLA

Tesla

$222.22

-3.48 (-1.54%)

10:00
08/21/19
08/21
10:00
08/21/19
10:00
Options
Tesla bear spends $318K on Oct downside »

Tesla bear spends $318K…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 23

    Sep

09:57
08/21/19
08/21
09:57
08/21/19
09:57
Conference/Events
The Food & Drug Law Institute to hold a webinar »

Anthony Anscombe, Partner…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.